- DVBCWCS1 ;ALB/CMM CUSHING'S SYNDROME WKS TEXT - 1 ; 5 MARCH 1997
- ;;2.7;AMIE;**12**;Apr 10, 1995
- ;
- ;
- TXT ;
- ;;A. Review of Medical Records:
- ;;
- ;;
- ;;
- ;;B. Medical History (Subjective Complaints):
- ;;
- ;; Comment on:
- ;; 1. Date diagnosis established.
- ;;
- ;;
- ;; 2. Weakness or fatigability.
- ;;
- ;;
- ;; 3. Etiology ? Iatrogenic?
- ;;
- ;;
- ;; 4. Treatments (surgery, medication, etc.), dose, frequency,
- ;; response, side effects.
- ;;
- ;;
- ;;C. Physical Examination (Objective Findings):
- ;;
- ;; Address each of the following and fully describe current findings:
- ;; 1. Muscle strength.
- ;;
- ;;
- ;; 2. Vascular fragility.
- ;;
- ;;
- ;; 3. Gastrointestinal.
- ;;
- ;;
- ;; 4. Blood Pressure.
- ;;
- ;;
- ;; 5. Striae.
- ;;
- ;;
- ;; 6. Weight gain or loss (weigh patient).
- ;;
- ;;
- ;; 7. Moonface.
- ;;
- ;;
- ;; 8. Glucose metabolism.
- ;;
- ;;
- ;; 9. After control, describe adrenal insufficiency, cardiovascular,
- ;; psychiatric, skin, or skeletal complications or residuals.
- ;;
- ;;
- ;;D. Diagnostic and Clinical Tests:
- ;;
- ;; Provide:
- ;; 1. CT of brain or X-ray of sella turcica.
- ;; 2. Serum and urine cortisol levels.
- ;; 3. High and low dose dexamethasone suppression test.
- ;; 4. X-rays if osteoporosis suspected.
- ;; 5. Include results of all diagnostic and clinical tests conducted
- ;; in the examination report.
- ;;
- ;;
- ;;E. Diagnosis:
- ;;
- ;; Comment on:
- ;; 1. Is the disease active or in remission?
- ;;
- ;;
- ;;Signature: Date:
- ;;END
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HDVBCWCS1 1658 printed Mar 13, 2025@20:54:51 Page 2
- DVBCWCS1 ;ALB/CMM CUSHING'S SYNDROME WKS TEXT - 1 ; 5 MARCH 1997
- +1 ;;2.7;AMIE;**12**;Apr 10, 1995
- +2 ;
- +3 ;
- TXT ;
- +1 ;;A. Review of Medical Records:
- +2 ;;
- +3 ;;
- +4 ;;
- +5 ;;B. Medical History (Subjective Complaints):
- +6 ;;
- +7 ;; Comment on:
- +8 ;; 1. Date diagnosis established.
- +9 ;;
- +10 ;;
- +11 ;; 2. Weakness or fatigability.
- +12 ;;
- +13 ;;
- +14 ;; 3. Etiology ? Iatrogenic?
- +15 ;;
- +16 ;;
- +17 ;; 4. Treatments (surgery, medication, etc.), dose, frequency,
- +18 ;; response, side effects.
- +19 ;;
- +20 ;;
- +21 ;;C. Physical Examination (Objective Findings):
- +22 ;;
- +23 ;; Address each of the following and fully describe current findings:
- +24 ;; 1. Muscle strength.
- +25 ;;
- +26 ;;
- +27 ;; 2. Vascular fragility.
- +28 ;;
- +29 ;;
- +30 ;; 3. Gastrointestinal.
- +31 ;;
- +32 ;;
- +33 ;; 4. Blood Pressure.
- +34 ;;
- +35 ;;
- +36 ;; 5. Striae.
- +37 ;;
- +38 ;;
- +39 ;; 6. Weight gain or loss (weigh patient).
- +40 ;;
- +41 ;;
- +42 ;; 7. Moonface.
- +43 ;;
- +44 ;;
- +45 ;; 8. Glucose metabolism.
- +46 ;;
- +47 ;;
- +48 ;; 9. After control, describe adrenal insufficiency, cardiovascular,
- +49 ;; psychiatric, skin, or skeletal complications or residuals.
- +50 ;;
- +51 ;;
- +52 ;;D. Diagnostic and Clinical Tests:
- +53 ;;
- +54 ;; Provide:
- +55 ;; 1. CT of brain or X-ray of sella turcica.
- +56 ;; 2. Serum and urine cortisol levels.
- +57 ;; 3. High and low dose dexamethasone suppression test.
- +58 ;; 4. X-rays if osteoporosis suspected.
- +59 ;; 5. Include results of all diagnostic and clinical tests conducted
- +60 ;; in the examination report.
- +61 ;;
- +62 ;;
- +63 ;;E. Diagnosis:
- +64 ;;
- +65 ;; Comment on:
- +66 ;; 1. Is the disease active or in remission?
- +67 ;;
- +68 ;;
- +69 ;;Signature: Date:
- +70 ;;END